Arterial hypertension, polyfactorial disease: attempt at understanding the interaction of inborn and acquired mechanisms
Meyer, P.
Revue Medicale de la Suisse Romande 103(5): 427-431
1983
ISSN/ISBN: 0035-3655 PMID: 6308744 Document Number: 220244
Document emailed within 1 workday
Related Documents
Xiong, C.-m. 2012: Correct understanding of the status of targeted drugs in the treatment of pulmonary arterial hypertension Zhonghua Yi Xue Za Zhi 92(22): 1515-1516Tokar', A.V.; Ena, L.M.; Rudaia, E.S.; Shmidt, A.D. 1980: Mechanisms of development of arterial hypertension in old age Vestnik Akademii Meditsinskikh Nauk SSSR 3: 57-64
Markov, K.M. 2001: Pathogenetic mechanisms of primary arterial hypertension in children and adolescents Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2: 46-48
de Aguiar, J.A. 1977: Blood pressure. Systemic arterial hypertension. Hypertensive arterial disease. A concept Amb: Revista da Associacao Medica Brasileira 23(2): 39-44
Bicho, M.P. 1988: Dopaminergic mechanisms in regulating the release of renin and aldosterone in arterial hypertension Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 7(2): 215-220
Volpe, M.; Ricciardelli, B.; De Luca, N.; Picotti, G.B.; Cuocolo, A.; Veniero, A.M.; De Simone, A.; Trimarco, B.; Condorelli, M. 1983: Study of the mechanisms of impaired beta-receptor responsiveness in arterial hypertension Cardiologia 28(6): 513-522
Martin, G.; Baumann, K.; Urmancheeva, T.G.; Vol'ter, F. 1986: Use of rhesus macaques in studying the mechanisms of development of primary arterial hypertension Vestnik Akademii Meditsinskikh Nauk SSSR 3: 33-37
Puddu, G.M.; Zito, M.; D'Andrea, L.; Cervone, C.; Lamanna, P.; Abate, G. 1996: Clinical aspects and pathogenetic mechanisms of cognitive impairment in arterial hypertension Minerva Cardioangiologica 44(6): 285-297
Iannaccone, A.; Carmignani, M.; Boscolo, P. 1981: Neurogenic and humoral mechanisms in arterial hypertension of chronically lead-exposed rats La Medicina del Lavoro 72(1): 13-21
Gerlach, M.; Desser, H.; Youdim, M.B.; Riederer, P. 1996: New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline Journal of Neural Transmission. Supplementum 48: 7-21
Marks, C.; Kuskov, S. 1995: Pattern of arterial aneurysms in acquired immunodeficiency disease World Journal of Surgery 19(1): 127-132
Razumovskiĭ, A.I.; Sharipov, A.M.; Bataev, S.-K.M.; Alkhasov, A.B.; Mitupov, Z.B.; Kulikova, N.V.; Zadverniuk, A.S.; Stepanenko, N.S. 2012: Early results of thoracoscopic treatment of inborn and acquired lung diseases in children Khirurgiia 12: 23-26
Pellegrino, L.; Prencipe, G. 1995: Ultrasonography of the carotid arteries in mild-to-moderate essential arterial hypertension and isolated systolic arterial hypertension Cardiologia 40(2): 109-116
Borovkov, N.N.; Sidorova, N.V. 2002: 24-hour arterial hypertension profile and heart rhythm variability in patients with arterial hypertension and NIDDM Klinicheskaia Meditsina 80(7): 19-21
Cloix, J.F.; Devynck, M.A.; Meyer, P. 1982: Plasma protein changes in essential arterial hypertension: a new genetic marker for arterial hypertension? Annales de Pediatrie 29(9): 655-656
Christenson, J.T.; Simonet, F.; Schmuziger, M. 1997: Hypertension, coronary disease and impact of arterial hypertension on results of coronary surgery Praxis 86(1-2): 9-12
Kauhanen, P.; Beer, J.H.; Lassila, R. 1997: Defective interaction between von Willebrand factor and platelet glycoprotein Ib--a familial study of peripheral arterial occlusive disease Thrombosis and Haemostasis 77(5): 849-855
Mucke, H.A.M. 2008: Pulmonary arterial hypertension: on the way to a manageable disease Current Opinion in Investigational Drugs 9(9): 957-962
Kocemba, J. 1973: Incidence of coronary disease in arterial hypertension Folia Medica Cracoviensia 15(4): 421-426
Bokarev, I.N. 2004: Arterial hypertension: is it a disease or a risk factor? Klinicheskaia Meditsina 82(9): 69-71